SEARCH

SEARCH BY CITATION

References

  • 1
    Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973–1983. Lancet 1986;2: 673677.
  • 2
    Tham BWL, Everard JE, Tidy JA, Drew D, Hancock BW. Gestational trophoblastic disease in the Asian population of Northern England and North Wales. Br J Obstet Gynaecol 2003;110(6):555559.
  • 3
    Paradinas FJ. The histological diagnosis of hydatidiform moles. Curr Diagn Pathol 1994;1: 2431.
  • 4
    Hancock BW. Differences in management and treatment: a critical appraisal. In: HancockBW, NewlandsES, BerkowitzRS, editors. Gestational Trophoblastic Disease. London: Chapman & Hall,1997: 211216.
  • 5
    The management of gestational trophoblastic disease. RCOG Clinical Guidelines. London: Royal College of Obstetricians and Gynaecologists, 1999.
  • 6
    Smith DB, Holden L, Newlands ES, Bagshawe KD. Correlation between clinical staging (FIGO) and prognostic groups with gestational trophoblastic disease. Br J Obstet Gynaecol 1993;100(2):157160.
  • 7
    Berkowitz RS, Goldstein DP. Presentation and management of molar pregnancy. In: HancockBW, NewlandsES, BerkowitzRS, editors. Gestational Trophoblastic Disease. London: Chapman & Hall Medical,1997: 127142.
  • 8
    Goto S, Yamada A, Ishizuka T, Tomoda Y. Development of postmolar trophoblastic disease after partial molar pregnancy. Gynecol Oncol 1993;48(2):165170.DOI: 10.1006/gyno.1993.1028
  • 9
    Bandy LC, Clarke-Pearson DL, Hammond CB. Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life. Obstet Gynecol 1984;64(3):395399.
  • 10
    Newlands ES. Investigations and treatment of patients with persistent gestational trophoblastic disease and gestational trophoblastic tumours in the UK. In: HancockBW, NewlandsES, BerkowitzRS, editors. Gestational Trophoblastic Disease. London: Chapman & Hall Medical,1997: 175192.
  • 11
    Sebire NJ, Fisher RA, Foskett M, Rees H, Seckl MJ, Newlands ES. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. Br J Obstet Gynaecol 2003;110(1):2226.
  • 12
    Seckl MJ, Fisher RA, Salerno G, et al. Choriocarcinoma and partial hydatidiform moles. Lancet 2000;356(9223):3639.DOI: 10.1016/S0140-6736(00)02432-6
  • 13
    FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia. Int J Obstet Gynaecol 2002;77: 285287.DOI: 10.1016/S0020-7292(02)00063-2
  • 14
    Gillespie AM, Kumar S, Hancock BW. Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy. Br J Cancer 2000;82(8):13931395.